| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 347.54B | 349.98B | 351.06B | 322.12B | 315.93B | 287.99B |
| Gross Profit | 70.95B | 73.87B | 78.78B | 67.98B | 58.05B | 61.91B |
| EBITDA | 31.72B | 34.07B | 32.50B | 24.71B | 17.61B | 22.74B |
| Net Income | 14.66B | 10.34B | 18.54B | 9.74B | 9.31B | 9.49B |
Balance Sheet | ||||||
| Total Assets | 444.97B | 462.60B | 472.79B | 447.80B | 411.18B | 406.90B |
| Cash, Cash Equivalents and Short-Term Investments | 50.62B | 47.92B | 62.95B | 57.98B | 55.55B | 64.84B |
| Total Debt | 73.19B | 63.44B | 83.93B | 89.90B | 85.85B | 80.39B |
| Total Liabilities | 182.50B | 185.38B | 199.03B | 192.14B | 183.30B | 179.94B |
| Stockholders Equity | 251.69B | 266.03B | 262.14B | 245.81B | 219.15B | 218.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.83B | 8.93B | 4.51B | -13.40B | -2.31B |
| Operating Cash Flow | 0.00 | 27.55B | 26.96B | 23.48B | 4.26B | 15.76B |
| Investing Cash Flow | 0.00 | -11.16B | -9.40B | -18.55B | -5.64B | -17.58B |
| Financing Cash Flow | 0.00 | -31.72B | -15.74B | -3.54B | -8.10B | -11.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥114.27B | 10.07 | ― | 3.72% | 5.40% | 14.80% | |
71 Outperform | ¥20.25B | 4.28 | ― | 3.61% | 8.85% | 110.05% | |
69 Neutral | ¥2.35T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥414.98B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
66 Neutral | ¥174.29B | 16.34 | 5.91% | 2.82% | 1.52% | 8.47% | |
65 Neutral | ¥361.21B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |